SCHEMBL5570741

SCHEMBL5570741

CC(NC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.48
▸ F2 P00734 1/20 0.48
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ ITGB3 P05106 2/20 0.39
▸ ITGA2B P08514 2/20 0.39
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ P2RY1 P47900 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567060 0.88 F10 (0.46) F10F2CA1
SCHEMBL5570744 0.86 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5567062 0.84 F10 (0.46) F10F2ITGB3ITGA2BSLC6A2
SCHEMBL5566260 0.82 OPRK1 (0.47) F10F2CA1SMN1; SMN2
SCHEMBL5567238 0.81 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5569536 0.80 HPGDS (0.51) CA12CA1CA9
SCHEMBL5570724 0.79 F10 (0.50) F10F2CA12CA1CA9
SCHEMBL5569549 0.79 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5566762 0.78 F10 (0.47) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5566263 0.77 ROCK1 (0.51) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 — — EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 — — WO disclosed
Send feedback